Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047829
Filing Date
2024-11-14
Accepted
2024-11-14 14:31:47
Documents
96
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ffntf-20240930.htm   iXBRL 10-Q 1324756
2 EX-31.1 ffntf09302024exhibit311.htm EX-31.1 12741
3 EX-31.2 ffntf09302024exhibit312.htm EX-31.2 12964
4 EX-32.1 ffntf09302024exhibit321.htm EX-32.1 12072
  Complete submission text file 0001628280-24-047829.txt   8342709

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ffntf-20240930.xsd EX-101.SCH 77575
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ffntf-20240930_cal.xml EX-101.CAL 109338
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ffntf-20240930_def.xml EX-101.DEF 296612
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ffntf-20240930_lab.xml EX-101.LAB 708271
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ffntf-20240930_pre.xml EX-101.PRE 501836
98 EXTRACTED XBRL INSTANCE DOCUMENT ffntf-20240930_htm.xml XML 1222269
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 241460456
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)